Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation

Diabetologia

Volumn 56, Issue 1, 2013, Pages 162-172

  Balestrieri, M L ^a   Servillo, L ^a   Esposito, A ^a   D'Onofrio, N ^a   Giovane, A ^a   Casale, R ^a   Barbieri, M ^a   Paolisso, P ^a   Rizzo, M R ^a   Paolisso, G ^a   Marfella, R ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Endothelial progenitor cells; Platelet activating factor; SIRT1; Type 2 diabetes

Indexed keywords

[2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; ACARBOSE; ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MESSENGER RNA; METFORMIN; SIRTUIN 1; SULFONYLUREA DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD BUFFY COAT; CELL COUNT; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIABETIC PATIENT; ENDOTHELIAL PROGENITOR CELL; FEMALE; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; ADULT STEM CELLS; AGED; BLOOD BUFFY COAT; CELL COUNT; CELL SEPARATION; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PHOSPHOLIPID ETHERS; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIRTUIN 1;

EID: 84871619202     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2749-0     Document Type: Article

References (41)

1. Fadini GP, Losordo D, Dimmeler S (2012) Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 110:624-637
2. Napoli C, William-Ignarro S, Byrns R et al. (2008) Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia. Nat Clin Pract Cardiovasc Med 5:571-579
3. Jarajapu YP, Grant MB (2010) The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ Res 106:854-869
4. Tepper OM, Galiano RD, Capla JM et al. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786 (Pubitemid 35396976)
5. Fadini GP, Boscaro E, de Kreutzenberg S et al. (2010) Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes mellitus. Diabetes Care 33:1097-1102
6. Loomans CJ, de Koning EJ, Staal FJ et al. (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:195-199 (Pubitemid 38044715)
7. Liguori A, Fiorito C, Balestrieri ML et al. (2008) Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. Eur J Haematol 80:258-264 (Pubitemid 351253458)
8. Fadini GP, Miorin M, Facco M et al. (2005) Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45:1449-1457 (Pubitemid 40615617)
9. Chen YH, Lin SJ, Lin FY et al. (2007) High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 56:1559-1568 (Pubitemid 46842612)
10. Zhang J, Zhang X, Li H et al. (2012) Hyperglycaemia exerts deleterious effects on late endothelial progenitor cell secretion actions. Diabetes Vasc Dis Res. doi: 10.1177/1479164112444639
11. Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ (2012) Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol 53:64-72
12. Li H, Zhang X, Guan X et al. (2012) Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells. Cardiovasc Diabetol 11:46
13. Chen J, Song M, Yu S et al. (2010) Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress. Mol Cell Biochem 335:137-146
14. Chen Q, Dong L, Wang L, Kang L, Xu B (2009) Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2. Biochem Biophys Res Commun 381:192-197
15. Zhang Y, Ingram DA, Murphy MP et al. (2009) Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol 296:H1675-H1682
16. Zhang Y, Herbert BS, Rajashekhar G et al. (2009) Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway. FASEB J 23:1358-1365
17. Seeger FH, Haendeler J, Walter DH et al. (2005) p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111:1184-1191 (Pubitemid 40365481)
18. Balestrieri ML, Schiano C, Felice F et al. (2008) Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells. J Biochem 143:179-186 (Pubitemid 351249832)
19. Balestrieri ML, Giovane A, Milone L, Servillo L (2010) Endothelial progenitor cells express PAF receptor and respond to PAF via Ca(2+)-dependent signaling. Biochim Biophys Acta 1801:1123-1132
20. Balestrieri ML, Castaldo D, Balestrieri C, Quagliuolo L, Giovane A, Servillo L (2003) Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. J Lipid Res 44:380-387 (Pubitemid 37287781)
21. Balestrieri ML, Servillo L, Lee T (1997) The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn- glycero-3-phosphocholine by stimulated endothelial cells. J Biol Chem 272:17431-17437 (Pubitemid 27311173)
22. Guarente L, Picard F (2005) Calorie restriction-the SIR2 connection. Cell 120:473-482 (Pubitemid 40269762)
23. Brunet A, Sweeney LB, Sturgill JF et al. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011-2015 (Pubitemid 38393275)
24. Lemarié CA, ShbAt L, Marchesi C et al. (2011) Mthfr deficiency induces endothelial progenitor cell senescence via uncoupling of eNOS and downregulation of SIRT1. Am J Physiol Heart Circ Physiol 300:H745-H753
25. Sanchez-Fidalgo S, Villegas I, Sanchez-Hidalgo M, de la Lastra CA (2012) Sirtuin modulators: mechanisms and potential clinical implications. Curr Med Chem 19:2414-2441
26. Balestrieri ML, Rienzo M, Felice F et al. (2008) High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim Biophys Acta 1784:936-945
27. de Kreutzenberg SV, Ceolotto G, Papparella I et al. (2010) Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59:1006-1015
28. Yang SR, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I (2007) Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 292:L567-L576
29. Yang Z, Kahn BB, Shi H, Xue BZ (2010) Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem 285:19051-19059
30. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschöp MH (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 105:9793-9798 (Pubitemid 352031379)
31. American Diabetes Association: Clinical practice recommendation (2011) Diabetes Care 25 (Suppl 1):S1-S147
32. van Ark J, Moser J, Lexis CP et al. (2012) Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers. Diabetologia 55:2501-2512
33. Krankel N, Adams V, Linke A et al. (2005) Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol 25:698-703 (Pubitemid 40463856)
34. Sica V, Williams-Ignarro S, de Nigris F et al. (2006) Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb. Cell Cycle 5:2903-2908 (Pubitemid 44953945)
35. Fadini GP (2011) Is bone marrow another target of diabetic complications? Eur J Clin Invest 41:457-463
36. Humpert PM, Neuwirth R, Battista MJ et al. (2005) Sdf-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes. Diabetes Care 28:934-936 (Pubitemid 40434501)
37. Balestrieri ML, Balestrieri A, Mancini FP, Napoli C (2008) Understanding the immunoangiostatic CXC chemokine network. Cardiovasc Res 78:250-256 (Pubitemid 351556103)
38. Fiorito C, Rienzo M, Crimi E et al. (2008) Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways. Free Radic Res 42:754-762
39. Yoshizaki T, Schenk S, Imamura T et al. (2010) SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 298:E419-E428
40. Servillo L, Balestrieri C, Giovane A et al. (2006) Lysophospholipid transacetylase in the regulation of PAF levels in human monocytes and macrophages. FASEB J 20:1015-1017 (Pubitemid 44943934)
41. Pulla VK, Battu MB, Alvala M, Sriram D, Yogeeswari P (2012) Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review. Expert Opin Ther Targets 16:819-832